| Articles Reviewed |
| 1: | Pabbisetty Sudheer Kumar et al. Differential expression and role of p21cip/waf1 and p27kip1 in TNF-alpha-induced inhibition of proliferation in human glioma cells. 2007 |
| 2: | Natalie J Thornburg et al. Induction of epidermal growth factor receptor expression by Epstein-Barr virus latent membrane protein 1 C-terminal-activating region 1 is mediated by NF-kappaB p50 homodimer/Bcl-3 complexes. 2007 |
| 3: | Jiping Zhang et al. NFkappaB1/p50 is not required for tumor necrosis factor-stimulated growth of primary mammary epithelial cells: implications for NFkappaB2/p52 and RelB. 2007 |
| 4: | D-Y Lu et al. YC-1 attenuates LPS-induced proinflammatory responses and activation of nuclear factor-kappaB in microglia. 2007 |
| 5: | Zhiqiang Zhang et al. Transcription termination factor Pcf11 limits the processivity of Pol II on an HIV provirus to repress gene expression. 2007 |
| 6: | Yutaka Kida et al. Serratia marcescens serralysin induces inflammatory responses through protease-activated receptor 2. 2007 |
| 7: | Randall L Davis et al. The opioid antagonist, beta-funaltrexamine, inhibits chemokine expression in human astroglial cells. 2007 |
| 8: | Katrin Schweitzer et al. CSN controls NF-kappaB by deubiquitinylation of IkappaBalpha. 2007 |
| 9: | Hittu Matta et al. Kaposi's sarcoma-associated herpesvirus (KSHV) oncoprotein K13 bypasses TRAFs and directly interacts with the IkappaB kinase complex to selectively activate NF-kappaB without JNK activation. 2007 |
| 10: | Nancy L Vogel et al. Spermidine/Spermine N1-Acetyltransferase 2 (SSAT2) functions as a coactivator for NF-kappaB and cooperates with CBP and P/CAF to enhance NF-kappaB-dependent transcription. 2006 |
| 11: | Noriyuki Uemura et al. TAK1 is a component of the Epstein-Barr virus LMP1 complex and is essential for activation of JNK but not of NF-kappaB. 2006 |
| 12: | Kazi Nazrul Islam et al. Permissive effects of oxygen on cyclic AMP and interleukin-1 stimulation of surfactant protein A gene expression are mediated by epigenetic mechanisms. 2006 |
| 13: | Bryan D Griffin et al. Persistent interleukin-1beta signaling causes long term activation of NFkappaB in a promoter-specific manner in human glial cells. 2006 |
| 14: | Sylvia M Major et al. AbMiner: a bioinformatic resource on available monoclonal antibodies and corresponding gene identifiers for genomic, proteomic, and immunologic studies. 2006 |
| 15: | Ping Hu et al. Autocrine tumor necrosis factor alpha links endoplasmic reticulum stress to the membrane death receptor pathway through IRE1alpha-mediated NF-kappaB activation and down-regulation of TRAF2 expression. 2006 |
| 16: | Nobutaka Suzuki et al. A critical role for the innate immune signaling molecule IRAK-4 in T cell activation. 2006 |
| 17: | Yoon-Jae Song et al. IL-1 receptor-associated kinase 1 is critical for latent membrane protein 1-induced p65/RelA serine 536 phosphorylation and NF-kappaB activation. 2006 |
| 18: | Lakshmanan Ganesh et al. Protein methyltransferase 2 inhibits NF-kappaB function and promotes apoptosis. 2006 |
| 19: | Bastian Opitz et al. Legionella pneumophila induces IFNbeta in lung epithelial cells via IPS-1 and IRF3, which also control bacterial replication. 2006 |
| 20: | Michael A James et al. Human papillomavirus type 16 E6 activates NF-kappaB, induces cIAP-2 expression, and protects against apoptosis in a PDZ binding motif-dependent manner. 2006 |
| 21: | Jung-Hyun Choi et al. Inhibitor kappaB and nuclear factor kappaB in granulocyte-macrophage colony-stimulating factor antagonism of dexamethasone suppression of the macrophage response to Aspergillus fumigatus conidia. 2006 |
| 22: | Yuan Liu et al. Breast cancer metastasis suppressor 1 functions as a corepressor by enhancing histone deacetylase 1-mediated deacetylation of RelA/p65 and promoting apoptosis. 2006 |
| 23: | Wen-Hui Hu et al. NIBP, a novel NIK and IKK(beta)-binding protein that enhances NF-(kappa)B activation. 2005 |
| 24: | Yushi Bai et al. Persistent nuclear factor-kappa B activation in Ucp2-/- mice leads to enhanced nitric oxide and inflammatory cytokine production. 2005 |
| 25: | Hans F Luecke et al. The glucocorticoid receptor blocks P-TEFb recruitment by NFkappaB to effect promoter-specific transcriptional repression. 2005 |
| 26: | Sheikh Showkat Rahim et al. Interleukin-10 (IL-10) mediated suppression of IL-12 production in RAW 264.7 cells also involves c-rel transcription factor. 2005 |
| 27: | Sewon Kang et al. Inflammation and extracellular matrix degradation mediated by activated transcription factors nuclear factor-kappaB and activator protein-1 in inflammatory acne lesions in vivo. 2005 |
| 28: | Shashirekha Shetty et al. Transcription factor NF-kappaB differentially regulates death receptor 5 expression involving histone deacetylase 1. 2005 |
| 29: | Vaneeta Marwaha et al. T-oligo treatment decreases constitutive and UVB-induced COX-2 levels through p53- and NFkappaB-dependent repression of the COX-2 promoter. 2005 |
| 30: | Qingli Xiao et al. Characterization of cis-regulatory elements of the vascular endothelial growth inhibitor gene promoter. 2005 |
| 31: | Bysani Chandrasekar et al. Interleukin-18 is a pro-hypertrophic cytokine that acts through a phosphatidylinositol 3-kinase-phosphoinositide-dependent kinase-1-Akt-GATA4 signaling pathway in cardiomyocytes. 2005 |
| 32: | Mei Nie et al. Differential regulation of chemokine expression by peroxisome proliferator-activated receptor gamma agonists: interactions with glucocorticoids and beta2-agonists. 2005 |
| 33: | Hitoshi Ogawa et al. Mechanisms of MAdCAM-1 gene expression in human intestinal microvascular endothelial cells. 2005 |
| 34: | Hua Cheng et al. Molecular mechanism of hTid-1, the human homolog of Drosophila tumor suppressor l(2)Tid, in the regulation of NF-kappaB activity and suppression of tumor growth. 2005 |
| 35: | Ryuichi Mashima et al. FLN29, a novel interferon- and LPS-inducible gene acting as a negative regulator of toll-like receptor signaling. 2005 |
| 36: | Michiyo Koyanagi et al. Centrosomal P4.1-associated protein is a new member of transcriptional coactivators for nuclear factor-kappaB. 2005 |
| 37: | Dong-Kee Lee et al. FBI-1 enhances transcription of the nuclear factor-kappaB (NF-kappaB)-responsive E-selectin gene by nuclear localization of the p65 subunit of NF-kappaB. 2005 |
| 38: | Ling-Chi Wang et al. Tumor necrosis factor alpha-dependent drug resistance to purine and pyrimidine analogues in human colon tumor cells mediated through IKK. 2005 |
| 39: | Soo-Jin Jeong et al. A novel NF-kappaB pathway involving IKKbeta and p65/RelA Ser-536 phosphorylation results in p53 Inhibition in the absence of NF-kappaB transcriptional activity. 2005 |
| 40: | Chaitali Basak et al. NF-kappaB- and C/EBPbeta-driven interleukin-1beta gene expression and PAK1-mediated caspase-1 activation play essential roles in interleukin-1beta release from Helicobacter pylori lipopolysaccharide-stimulated macrophages. 2005 |
| 41: | Zhongkui Li et al. Function of polo-like kinase 3 in NF-kappaB-mediated proapoptotic response. 2005 |
| 42: | Deok-Soo Son et al. Tumor necrosis factor-alpha induces serum amyloid A3 in mouse granulosa cells. 2004 |
| 43: | Susan E McNulty et al. Comparative expression of NFkappaB proteins in melanocytes of normal skin vs. benign intradermal naevus and human metastatic melanoma biopsies. 2004 |
| 44: | Holger Buss et al. Phosphorylation of serine 468 by GSK-3beta negatively regulates basal p65 NF-kappaB activity. 2004 |
| 45: | Jing Deng et al. Translational repression mediates activation of nuclear factor kappa B by phosphorylated translation initiation factor 2. 2004 |
| 46: | Enrique Lara-Pezzi et al. Evidence of a transcriptional co-activator function of cohesin STAG/SA/Scc3. 2004 |
| 47: | Chun-Fung Chan et al. Evaluation of nuclear factor-kappaB, urokinase-type plasminogen activator, and HBx and their clinicopathological significance in hepatocellular carcinoma. 2004 |
| 48: | Holger Buss et al. Constitutive and interleukin-1-inducible phosphorylation of p65 NF-{kappa}B at serine 536 is mediated by multiple protein kinases including I{kappa}B kinase (IKK)-{alpha}, IKK{beta}, IKK{epsilon}, TRAF family member-associated (TANK)-binding kinase 1 (TBK. 2004 |
| 49: | Mary H Ritchie et al. A role for NF-kappa B binding motifs in the differential induction of chemokine gene expression in human corneal epithelial cells. 2004 |
| 50: | Bysani Chandrasekar et al. Activation of intrinsic and extrinsic proapoptotic signaling pathways in interleukin-18-mediated human cardiac endothelial cell death. 2004 |
| 51: | D Gregory et al. Efficient replication by herpes simplex virus type 1 involves activation of the IkappaB kinase-IkappaB-p65 pathway. 2004 |
| 52: | Derek Strassheim et al. Phosphoinositide 3-kinase and Akt occupy central roles in inflammatory responses of Toll-like receptor 2-stimulated neutrophils. 2004 |
| 53: | Guang Yang et al. Maturational differences in lung NF-kappaB activation and their role in tolerance to hyperoxia. 2004 |
| 54: | Ivan Mattioli et al. Comparative analysis of T-cell costimulation and CD43 activation reveals novel signaling pathways and target genes. 2004 |
| 55: | Bingbing Jiang et al. Angiotensin II differentially regulates interleukin-1-beta-inducible NO synthase (iNOS) and vascular cell adhesion molecule-1 (VCAM-1) expression: role of p38 MAPK. 2004 |
| 56: | Hyun Duk Jang et al. PIAS3 suppresses NF-kappaB-mediated transcription by interacting with the p65/RelA subunit. 2004 |
| 57: | Manuel A Sepulveda et al. NF-kappa B and Oct-2 synergize to activate the human 3' Igh hs4 enhancer in B cells. 2004 |
| 58: | Khandaker N Anwar et al. RhoA/Rho-associated kinase pathway selectively regulates thrombin-induced intercellular adhesion molecule-1 expression in endothelial cells via activation of I kappa B kinase beta and phosphorylation of RelA/p65. 2004 |
| 59: | Pedro A Ruiz et al. 15-deoxy-delta12,14-prostaglandin J2-mediated ERK signaling inhibits gram-negative bacteria-induced RelA phosphorylation and interleukin-6 gene expression in intestinal epithelial cells through modulation of protein phosphatase 2A activity. 2004 |
| 60: | Jun Zhang et al. Identification of a ZU5 and death domain-containing inhibitor of NF-kappaB. 2004 |
| 61: | Md Ruhul Abid et al. Vascular endothelial growth factor-mediated induction of manganese superoxide dismutase occurs through redox-dependent regulation of forkhead and IkappaB/NF-kappaB. 2004 |
| 62: | Huabao Xiong et al. Inhibition of interleukin-12 p40 transcription and NF-kappaB activation by nitric oxide in murine macrophages and dendritic cells. 2004 |
| 63: | Christian Maihöfner et al. Expression of cyclooxygenase-2 parallels expression of interleukin-1beta, interleukin-6 and NF-kappaB in human colorectal cancer. 2003 |
| 64: | Harald Jakob Maier et al. Critical role of RelB serine 368 for dimerization and p100 stabilization. 2003 |
| 65: | M A Christine Pratt et al. Estrogen withdrawal-induced NF-kappaB activity and bcl-3 expression in breast cancer cells: roles in growth and hormone independence. 2003 |
| 66: | Rosemary Kiernan et al. Post-activation turn-off of NF-kappa B-dependent transcription is regulated by acetylation of p65. 2003 |
| 67: | Mario Delgado et al. Inhibition of interferon (IFN) gamma-induced Jak-STAT1 activation in microglia by vasoactive intestinal peptide: inhibitory effect on CD40, IFN-induced protein-10, and inducible nitric-oxide synthase expression. 2003 |
| 68: | Ina Poser et al. Upregulation of HMG1 leads to melanoma inhibitory activity expression in malignant melanoma cells and contributes to their malignancy phenotype. 2003 |
| 69: | Mei Nie et al. Transcriptional regulation of cyclooxygenase 2 by bradykinin and interleukin-1beta in human airway smooth muscle cells: involvement of different promoter elements, transcription factors, and histone h4 acetylation. 2003 |
| 70: | Nadia El-Guendy et al. Identification of a unique core domain of par-4 sufficient for selective apoptosis induction in cancer cells. 2003 |
| 71: | Dirk Haller et al. Transforming growth factor-beta 1 inhibits non-pathogenic Gram negative bacteria-induced NF-kappa B recruitment to the interleukin-6 gene promoter in intestinal epithelial cells through modulation of histone acetylation. 2003 |
| 72: | Hao-Yuan Jiang et al. Phosphorylation of the alpha subunit of eukaryotic initiation factor 2 is required for activation of NF-kappaB in response to diverse cellular stresses. 2003 |
| 73: | Peter Stärkel et al. Expression and DNA-binding activity of signal transducer and activator of transcription 3 in alcoholic cirrhosis compared to normal liver and primary biliary cirrhosis in humans. 2003 |
| 74: | Hiroaki Sakurai et al. Tumor necrosis factor-alpha-induced IKK phosphorylation of NF-kappaB p65 on serine 536 is mediated through the TRAF2, TRAF5, and TAK1 signaling pathway. 2003 |
| 75: | Raphaëlle Romieu-Mourez et al. Mouse mammary tumor virus c-rel transgenic mice develop mammary tumors. 2003 |
| 76: | M Zahidunnabi Dewan et al. Rapid tumor formation of human T-cell leukemia virus type 1-infected cell lines in novel NOD-SCID/gammac(null) mice: suppression by an inhibitor against NF-kappaB. 2003 |
| 77: | Gary Guishan Xiao et al. Use of proteomics to demonstrate a hierarchical oxidative stress response to diesel exhaust particle chemicals in a macrophage cell line. 2003 |
| 78: | Sébastien Jeay et al. Lysyl oxidase inhibits ras-mediated transformation by preventing activation of NF-kappa B. 2003 |
| 79: | Wu-Guo Deng et al. Regulation of inducible nitric oxide synthase expression by p300 and p50 acetylation. 2003 |
| 80: | Ganapati H Mahabeleshwar et al. Tyrosine kinase p56lck regulates cell motility and nuclear factor kappaB-mediated secretion of urokinase type plasminogen activator through tyrosine phosphorylation of IkappaBalpha following hypoxia/reoxygenation. 2003 |
| 81: | Kim Estell et al. Plasma membrane CFTR regulates RANTES expression via its C-terminal PDZ-interacting motif. 2003 |
| 82: | LluÃs Espinosa et al. IkappaBalpha and p65 regulate the cytoplasmic shuttling of nuclear corepressors: cross-talk between Notch and NFkappaB pathways. 2003 |
| 83: | Chiara Fiorentini et al. Nerve growth factor regulates dopamine D(2) receptor expression in prolactinoma cell lines via p75(NGFR)-mediated activation of nuclear factor-kappaB. 2002 |
| 84: | Christos Chadjichristos et al. Down-regulation of human type II collagen gene expression by transforming growth factor-beta 1 (TGF-beta 1) in articular chondrocytes involves SP3/SP1 ratio. 2002 |
| 85: | Pascal Knuefermann et al. Myotrophin/V-1, a protein up-regulated in the failing human heart and in postnatal cerebellum, converts NFkappa B p50-p65 heterodimers to p50-p50 and p65-p65 homodimers. 2002 |
| 86: | Yutaka Kida et al. Opposing roles of activator protein-1 and CCAAT/enhancer binding protein beta in the regulation of inducible granulysin gene expression in a human monocytic cell line, THP-1. 2002 |
| 87: | Dirk Haller et al. IKK beta and phosphatidylinositol 3-kinase/Akt participate in non-pathogenic Gram-negative enteric bacteria-induced RelA phosphorylation and NF-kappa B activation in both primary and intestinal epithelial cell lines. 2002 |
| 88: | Kaoru Saijo et al. Protein kinase C beta controls nuclear factor kappaB activation in B cells through selective regulation of the IkappaB kinase alpha. 2002 |
| 89: | Charlie D Chen et al. NF-kappa B activates prostate-specific antigen expression and is upregulated in androgen-independent prostate cancer. 2002 |
| 90: | Sergio D Catz et al. JFC1 is transcriptionally activated by nuclear factor-kappaB and up-regulated by tumour necrosis factor alpha in prostate carcinoma cells. 2002 |
| 91: | T Hideshima et al. The proteasome inhibitor PS-341 inhibits growth, induces apoptosis, and overcomes drug resistance in human multiple myeloma cells. 2001 |
| 92: | M Ruiz-Ortega et al. Systemic infusion of angiotensin II into normal rats activates nuclear factor-kappaB and AP-1 in the kidney: role of AT(1) and AT(2) receptors.. 2001 |
| 93: | M Melnick et al. The functional genomic response of developing embryonic submandibular glands to NF-kappa B inhibition.. 2001 |
| 94: | P C Lucas et al. Bcl10 and MALT1, independent targets of chromosomal translocation in malt lymphoma, cooperate in a novel NF-kappa B signaling pathway. 2001 |